Reduced high-density lipoprotein level is linked to worse ankle brachial index and peak oxygen uptake in postmenopausal women with peripheral arterial disease

Angiology

Volumn 61, Issue 7, 2010, Pages 698-704

  Mauer, Karin ^a   Exaire, J Emilio ^a   Stoner, Julie A ^b   Guthery, Leslie D ^a   Montgomery, Polly S ^b   Gardner, Andrew W ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

dyslipidemia; peripheral arterial disease; postmenopausal; women

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY DISEASE; ARTICLE; CLAUDICATION; EXERCISE; FEMALE; HUMAN; OXYGEN CONSUMPTION; POSTMENOPAUSE; TREADMILL; AGED; ANKLE BRACHIAL INDEX; BLOOD; CROSS-SECTIONAL STUDY; EXERCISE TEST; INTERMITTENT CLAUDICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; SKELETAL MUSCLE;

AGED; ANKLE BRACHIAL INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; EXERCISE TEST; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MIDDLE AGED; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PERIPHERAL VASCULAR DISEASES; POSTMENOPAUSE;

EID: 77956478721     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319710369100     Document Type: Article

References (45)

1. Pradhan AD, Shrivastava S., Cook NR, Rifai N., Creager MA, Ridker PM Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation. 2008 ; 117 (6). 823-831.
2. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001 ; 285 (19). 2481-2485.
3. McDermott MM, Greenland P., Liu K., et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002 ; 136 (12). 873-883.
4. McDermott MM, Liu K., Greenland P., et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004 ; 292 (4). 453-461.
5. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006 ; 47 (6). 1239-1312.
6. Aboyans V., Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation. 2006 ; 113 (22). 2623-2629.
7. Singh IM, Shishehbor MH, Ansell BJ High-density lipoprotein as a therapeutic target: a systematic review. JAMA. 2007 ; 298 (7). 786-798.
8. Afaq A., Montgomery P., Scott K., Blevins S., Whitsett T., Gardner A. The Effect of Hypercholestrolemia on Calf Muscle Hemoglobin Oxygen Saturation in Patients With Intermittent Claudication. Angiology. 2008 ; 59 (5). 534-541. Epub 2008 Apr 2.
9. Brevetti G., Bucur R., Balbarini A., et al. Women and peripheral arterial disease: same disease, different issues. J Cardiovasc Med (Hagerstown). 2008 ; 9 (4). 382-388.
10. Collins TC, Suarez-Almazor M., Bush RL, Petersen NJ Gender and peripheral arterial disease. J Am Board Fam Med. 2006 ; 19 (2). 132-140.
11. Gardner AW Sex differences in claudication pain in subjects with peripheral arterial disease. Med Sci Sports Exerc. 2002 ; 34 (11). 1695-1698.
12. Garrison RJ, Kannel WB, Feinleib M., Castelli WP, McNamara PM, Padgett SJ Cigarette smoking and HDL cholesterol: the Framingham offspring study. Atherosclerosis. 1978 ; 30 (1). 17-25.
13. Heyden S., Heiss G., Manegold C., et al. The combined effect of smoking and coffee drinking on LDL and HDL cholesterol. Circulation. 1979 ; 60 (1). 22-25.
14. Willett W., Hennekens CH, Castelli W., et al. Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. Am Heart J. 1983 ; 105 (3). 417-421.
15. Gardner AW, Skinner JS, Cantwell BW, Smith LK Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991 ; 23 (4). 402-408.
16. Weitz JI, Byrne J., Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996 ; 94 (11). 3026-3049.
17. Mosca L., Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007 ; 115 (11). 1481-1501. (Pubitemid 46648385)
18. Brunzell JD, Davidson M., Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2008 ; 51 (15). 1512-1524.
19. McDermott MM, Liu K., Guralnik JM, Martin GJ, Criqui MH, Greenland P. Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease. J Vasc Surg. 1998 ; 28 (6). 1072-1081.
20. Gardner AW, Killewich LA, Katzel LI, et al. Relationship between free-living daily physical activity and peripheral circulation in patients with intermittent claudication. Angiology. 1999 ; 50 (4). 289-297.
21. Gardner AW, Skinner JS, Smith LK Effects of handrail support on claudication and hemodynamic responses to single-stage and progressive treadmill protocols in peripheral vascular occlusive disease. Am J Cardiol. 1991 ; 68 (1). 99-105.
22. Feinberg RL, Gregory RT, Wheeler JR, et al. The ischemic window: a method for the objective quantitation of the training effect in exercise therapy for intermittent claudication. J Vasc Surg. 1992 ; 16 (2). 244-250.
23. Gardner AW Reliability of transcutaneous oximeter electrode heating power during exercise in patients with intermittent claudication. Angiology. 1997 ; 48 (3). 229-235.
24. Komiyama T., Onozuka A., Miyata T., Shigematsu H. Oxygen saturation measurement of calf muscle during exercise in intermittent claudication. Eur J Vasc Endovasc Surg. 2002 ; 23 (5). 388-392.
25. Casavola C., Paunescu LA, Fantini S., Franceschini MA, Lugara PM, Gratton E. Application of near-infrared tissue oxymetry to the diagnosis of peripheral vascular disease. Clin Hemorheol Microcirc. 1999 ; 21 (3-4). 389-393.
26. Comerota AJ, Throm RC, Kelly P., Jaff M. Tissue (muscle) oxygen saturation (StO2): a new measure of symptomatic lower-extremity arterial disease. J Vasc Surg. 2003 ; 38 (4). 724-729.
27. Gardner AW, Parker DE, Webb N., Montgomery PS, Scott KJ, Blevins SM Calf muscle hemoglobin oxygen saturation characteristics and exercise performance in patients with intermittent claudication. J Vasc Surg. 2008 ; 48 (3). 644-649.
28. Gardner AW, Sieminski DJ, Killewich LA The effect of cigarette smoking on free-living daily physical activity in older claudication patients. Angiology. 1997 ; 48 (11). 947-955.
29. Daskalopoulou SS, Pathmarajah M., Kakkos SK, et al. Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J. 2008 ; 72 (3). 441-448.
30. Volpato S., Ble A., Metter EJ, et al. High-density lipoprotein cholesterol and objective measures of lower extremity performance in older nondisabled persons: the InChianti study. J Am Geriatr Soc. 2008 ; 56 (4). 621-629.
31. Landi F., Russo A., Cesari M., Pahor M., Bernabei R., Onder G. HDL-cholesterol and physical performance: results from the ageing and longevity study in the sirente geographic area (ilSIRENTE Study). Age Ageing. 2007 ; 36 (5). 514-520. (Pubitemid 47554940)
32. Barretto S., Ballman KV, Rooke TW, Kullo IJ Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location. Vasc Med. 2003 ; 8 (2). 95-100.
33. Nofer JR, Walter M., Assmann G. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence. Expert Rev Cardiovasc Ther. 2005 ; 3 (6). 1071-1086.
34. Murphy AJ, Chin-Dusting JP, Sviridov D., Woollard KJ The anti inflammatory effects of high density lipoproteins. Curr Med Chem. 2009 ; 16 (6). 667-675.
35. Moriarty PM, Gibson CA Association between hematological parameters and high-density lipoprotein cholesterol. Curr Opin Cardiol. 2005 ; 20 (4). 318-323.
36. Miura S., Fujino M., Matsuo Y., et al. High density lipoprotein-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2003 ; 23 (5). 802-808.
37. Sumi M., Sata M., Miura S., et al. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2007 ; 27 (4). 813-818.
38. Poussa H., Strandberg TE, Tikkanen I., Kauhanen P., Lepantalo M. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease. Scand Cardiovasc J. 2007 ; 41 (3). 138-141.
39. Margeta C., Giurgea A., Hammer A., et al. Impact of international guidelines on the manage-ment of cardiovascular risk factors in diabetic patients with peripheral arterial disease. Int Angiol. 2009 ; 28 (3). 175-180.
40. McDermott MM, Guralnik JM, Greenland P., et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation. 2003 ; 107 (5). 757-761.
41. Mohler ER 3rd, Hiatt WR, Creager MA Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003 ; 108 (12). 1481-1486.
42. Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev. 2007: CD000123.
43. Leng GC, Price JF, Jepson RG Lipid-lowering for lower limb atherosclerosis. Cochrane Database Syst Rev. 2000: CD000123.
44. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007 ; 45 (4). 645-654 ; discussion 653-654.
45. Briel M., Ferreira-Gonzalez I., You JJ, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009 ; 338: b92.